- This meeting has passed.
ANCO’s Hematologic Malignancies Update 2022
September 17, 2022 @ 8:00 am - 12:30 pm
The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses.
The program takes place in :
Sacramento on September 17th
San Francisco on November 12th
Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will conclude by 12:30pm.
ANCO acknowledges the support of Adaptive Biotechnologies, ADC Therapeutics, Amgen, Beigene, Incyte Corporation, Kite Pharma, Merck, Sanofi Aventis, SeaGen, and Secura Bio in making this program possible.
Attendance is limited to the first 50 health care professionals per location.
“To me, ANCO is the regional oncology expert with the deepest local knowledge and resources. Like most oncologists I rely on ASCO as my national educational organization, but ANCO is a key local connection and an ideal bridge to the offerings of ASCO. If you belong to ASCO you should also be a member of ANCO. Together they provide comprehensive resources for Northern California oncologists.”
Tyler Paul Johnson, MD
Stanford Cancer Center